The International Journal of Academic Medicine (IJAM) represents a multi-organizational, cross-disciplinary voice of international medical academicians. Our principal participants and leadership come from three major academic organizations - The American College of Academic International Medicine (ACAIM), INDUSEM, and OPUS 12 Foundation, Inc. Each organization brings to the Editorial Board its own and unique perspective, high profile scientific contributors and reviewers, as well as rich leadership experience.
ACAIM was founded in 2016 and is dedicated to advancing the field of Academic International Medicine (AIM) in the United States and beyond. Specific goals of this fast-growing organization include the promotion of clinical, educational and scientific collaboration of AIM professionals; the creation of platform for coordination of academic, clinical and educational efforts involving AIM professionals; commitment to education and creation of new knowledge, guidelines, and policies in the area of AIM; the standardization of processes and objective measurements of academic and clinical productivity associated with the participation of U.S. AIM professionals in international endeavors.
INDUSEM is a voluntary movement which brings together academic innovators who work collaboratively and creatively to advance science and knowledge. With more than a decade of experience, INDUSEM dedicated substantial resources and expertise to advance health via education, research and quality patient care. Sustaining public health and policy development is an important part of this endeavor. Leadership, innovation and entrepreneurship are key fundamentals for growth and INDUSEM believes in fostering progress of individuals and the institutions through knowledge and innovation. Finally, the collaborative promotes exchange of knowledge and mutual development between Academic institutions, individuals and agencies in India, United States and the World.
OPUS 12 Foundation, Inc., provides both critical leadership and logistical support functions to IJAM Editors, staff, and contributors. With combined academic management experience of more than 3 decades, this well-established organization is pivotal to both academic and financial sustainability of IJAM, as well as quality maintenance / assurance of published content. In a way, OPUS 12 Foundation, Inc., is the control and coordination center of IJAM's multi-organizational, cross-disciplinary platform, creating synergies and closely coordinating efforts with both INDUSEM and ACAIM.
International Journal of Academic Medicine, advances the art and science of academic international medicine though diversity, equity, and inclusion worldwide. IJAM is a peer-reviewed online journal publishing 4 issues per year with print on demand options. The journal’s full text is available online at www.ijam-web.org. The journal allows free access (Open Access) to its contents and permits authors to self-archive final accepted version of the articles on any OAI-compliant institutional / subject-based repository.
As such, the journal aims to provide the much needed forum for high-level academic discussions involving global approaches and strategies to implementing a universal, world-wide platform of medical education and key competency training.
Abstracting and Indexing Information
The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris – Primo Central, Google Scholar, Hinari, Infotrieve, National Science Library, ProQuest, TDNet, Wanfang Data
The journal is indexed with, or included in, the following:
Emerging Sources Citation Index, Scimago Journal Ranking, SCOPUS, Web of Science
Journal Ethics
Wolters Kluwer and Journal/Association are committed to meeting and upholding standards of ethical behavior at all stages of the publication process. We follow closely the industry associations, such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE) and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to meet these requirements. For a summary of our specific policies regarding duplicate publication, conflicts of interest, patient consent, etc., please visit www.Medknow.com/EthicalGuidelines.asp
Open Access Publication and Creative Commons Licensing
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Digital Archiving
Wolters Kluwer Medknow provides for long-term digital preservation through two primary partnerships, Portico and CLOCKSS.
Portico is a leading digital preservation service worldwide. The content is preserved as an archival version and is not publically accessible via Portico, but is provided when required under specific conditions, such as discontinuation of the collection or catastrophic failure of the website.
CLOCKSS will enable any library to maintain their own archive of content from Wolters Kluwer Medknow and other publishers, with minimal technical effort and using cheaply available hardware.
Ahead of Print policy
Articles published online under the Ahead of Print model are considered published and can be cited and quoted using the DOI as the reference source. Wolters Kluwer Medknow has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.
Advertisements
While advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place to ensure the integrity of the journal and its content:
- "Pop-up" and "banner" ads appear on a random, rotating basis. The advertiser has no control or input over the pages where their ads appear.
- The Editorial Board has full and final approval over the content of all advertisements.
- Advertisers will never be shown any manuscripts or other content prior to publication.
About Us
